• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. RAPIDPOINT 500; RP500

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. RAPIDPOINT 500; RP500 Back to Search Results
Catalog Number 10697306
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/27/2022
Event Type  malfunction  
Manufacturer Narrative
Siemens has requested the instrument log files for further investigation.Investigation has been completed.After reviewing the data logs from the rapidpoint instruments, the issue of discrepantly high na+ recovery was found to be limited to and caused by the reported patient samples.The rapidpoint instruments were found to be functioning as intended.The na+ results for the patient sample were flagged for being 'high' and the immediate sample or calibration following it were flagged for 'sodium sensor interferent detected' on all the rapidpoint instruments.
 
Event Description
Customer reported discrepant low thb (total hemoglobin) results for a patient sample that was analyzed on their rp500 instrument compared to the thb results when a new sample was tested on a non-siemens instrument.There was no report of injury due to this event.
 
Manufacturer Narrative
On (b)(6) 2023 siemens released an urgent medical device correction communication to customers.Siemens healthcare diagnostics inc.Has determined that two drugs, perhexiline maleate and atomoxetine hydrochloride, may interfere with sodium results that are reported on the rapidpoint 500 and rapidpoint 500e blood gas systems.The presence of perhexiline maleate and atomoxetine hydrochloride has the potential to cause erroneously elevated sodium results which may lead to unrecognized hyponatremia and/or the inappropriate treatment of hypernatremia.Hyponatremia is associated with significant symptoms including nausea, malaise, headache, lethargy, obtundation and eventually seizures, coma, and respiratory arrest.Mitigations include the geographically restricted use of perhexiline maleate (which is mostly used in australia and new zealand), the short time-interval testing needs to occur after drug dosing for atomoxetine hydrochloride due to its short half-life, correlation of results with other electrolyte results such as chloride, historical sodium results, and the clinical history of the patient.Siemens healthcare diagnostics will be revising the rapidpoint 500 and rapidpoint 500e system operator's guide with information on the interfering substances.Once the revisions are completed, they will be available in siemens healthineers document library.
 
Event Description
Correction to intial report: this customer complaint was for discrepant sodium results, thb was not affected.The customer reported that their rp500 instrument gave a discrepant high sodium result on one patient compared to several sodium results generating from their laboratory analyzer from different samples.There is no report of injury due to this event.
 
Manufacturer Narrative
Information in sections b5 and b6 have been corrected.This customer complaint is for discrepant sodium only, hemoglobin is not affected.There is no indication that the drug interferences noted in mdr fu1 impact hemoglobin.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAPIDPOINT 500
Type of Device
RP500
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS MANUFACTURING, LTD.
northern road
chilton industrial estate
sudbury, CO10 2XQ
UK   CO10 2XQ
Manufacturer Contact
thomas myers
511 benedict avenue
tarrytown, NY 10591
MDR Report Key15825887
MDR Text Key307604740
Report Number3002637618-2022-00063
Device Sequence Number1
Product Code CHL
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K122539
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Remedial Action Notification
Type of Report Initial,Followup,Followup
Report Date 11/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number10697306
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/10/2022
Initial Date FDA Received11/18/2022
Supplement Dates Manufacturer Received09/26/2023
09/26/2023
Supplement Dates FDA Received10/16/2023
11/07/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Removal/Correction NumberCRR 3002637618-09-26-202
Patient Sequence Number1
-
-